Ellevest Inc’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Ellevest Inc’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1	Closed	–	–	1400
2020 Q1	$0	Buy	+1	New	+$95	﹤0.01%	1357

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Ellevest Inc's EVLO Position: Q2 2020 in Review

Ellevest Inc sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2020, closing a stake of 1 share.

Ellevest Inc first reported a position in EVLO in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 47 funds tracked by Wall St. Rank hold EVLO as of Q2 2020.

Ellevest Inc reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Ellevest Inc sold 1 Evelo Biosciences, Inc. Common Stock share in Q2 2020.
Ellevest Inc first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Ellevest Inc's Evelo Biosciences, Inc. Common Stock position peaked at $0 in Q1 2020.
47 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2020.

Based on Ellevest Inc's 13F filing for Q2 2020, filed 6 Jul 2020.